Featured Article
Targeting a specific receptor in the eye may benefit patients with age-related macular degeneration, a major cause of blindness worldwide.
Precision Oncology Today
Magazine
Beginning a New Era of Precision Alzheimer’s Therapeutics
Alzheimer’s is a disease associated with aging and impacts almost seven million people in the U.S. over the age of 65, with women and Black or Hispanic populations disproportionately affected by the condition. Finding an effective treatment for Alzheimer’s disease has proved to be a long and difficult quest.
5 Startups With Proteomics Potential Attracting Investor Cash
Investor appetite is growing for startups that can make proteomics faster, cheaper, and more informative for use in precision medicine. Here are five proteomics...
Trending on Inside Precision Medicine
Colorectal Cancer Screening Interval Could Be Extended
Screening intervals for individuals at average risk of colorectal cancer could be extended in guidelines to avoid unnecessary invasive examinations, Swedish research suggests.
New Treatment Target for Age-Related Macular Degeneration Discovered
Targeting a specific receptor in the eye may benefit patients with age-related macular degeneration, a major cause of blindness worldwide.
Long COVID Symptoms in Children Vary by Age
Symptoms associated with long COVID in children differ based on age, a finding that may help guide treatment.
